Drug major Novartis’ Swiss promoter, Novartis AG, has hired Citigroup Capital Markets as the sole broker for the proposed share sale to reduce stake in the Indian entity. The promoter Novartis AG intends to reduce its 1.42% stake in the Indian entity for meeting SEBI guidelines on the minimum public shareholding in the listed companies.
As of March 31, Novartis AG held 76.42% stake in Indian subsidiary. However, according to SEBI’s norm listed companies are required to have a minimum of 25% public shareholding by June this year.
Novartis India is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare.
| Company Name | CMP |
|---|---|
| Redington | 227.50 |
| Adani Enterprises | 2245.10 |
| Amrapali Industries | 17.99 |
| Rashi Peripheral | 476.20 |
| PDS | 293.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: